AMPE : Summary for Ampio Pharmaceuticals, Inc. - Yahoo Finance

We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. Markets open in 6 hrs 1 mins

Ampio Pharmaceuticals, Inc. (AMPE)


NYSE MKT - NYSE MKT Delayed Price. Currency in USD
Add to watchlist
0.92 -0.02 (-2.52%)
At close: 4:02PM EST
People also watch
ACRX ANTH MRNS ALIM AVEO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close 0.94
Open 0.96
Bid 0.00 x
Ask 0.00 x
Day's Range 0.92 - 0.97
52 Week Range 0.59 - 4.32
Volume 135,744
Avg. Volume 390,695
Market Cap 52.67M
Beta 0.26
PE Ratio (TTM) -1.87
EPS (TTM) -0.49
Earnings Date N/A
Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 14.00
Trade prices are not sourced from all markets
  • TheStreet.com 6 months ago

    7 Stocks Under $10 That Could Make You a Lot of Money

    When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

  • Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE)
    Insider Monkey 7 months ago

    Answering Two Most Important Questions Surrounding Ampio Pharmaceuticals Inc (AMPE)

    Ampio Pharmaceuticals Inc (NYSEMKT:AMPE) has recently reported topline from its PIVOT trial and the stock lost over 60% on the announcement last Thursday. From this decline alone, it’s clear that the company didn’t report anything great, but despite missing the primary endpoint in the trial, management is shooting for an approval on the data. What […]

  • 24/7 Wall St. 7 months ago

    4 Companies That Destroyed Shareholders Despite a Brexit Recovery

    Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to believe that this was just one big head fake. Some companies made runs in this ...

  • TheStreet.com 7 months ago

    Why Ampio Pharma (AMPE) Stock Is Plummeting Today

    Ampio Pharma (AMPE) stock is sharply lower this afternoon following a phase 3 trial for its osteoarthritis pain treatment.

  • 24/7 Wall St. 7 months ago

    Ampio Crashes After Late-Stage Trial Failure

    Ampio Pharmaceuticals, Inc. (NYSEMKT: AMPE) is watching its shares get cut in half on Thursday after news of a failed late-stage trial. The company announced the results of its Ampion PIVOT clinical trial ...

  • Ampio Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
    Capital Cube last year

    Ampio Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers

    Click here to see latest analysisAmpio Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2015.Ampio Pharmaceuticals, Inc. has an earnings momentum score of 54.22 and has a relative valuation rating of OVERVALUED. HighlightsSummary numbers: Revenues of USD 0.49 million, Net Earnings of USD -7.37 million, and Earnings per Share (EPS) of USD […] (Read more...) The post Ampio Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers appeared first on CapitalCube.

  • Ampio Pharmaceuticals, Inc. Earnings Q2, 2015
    Capital Cube last year

    Ampio Pharmaceuticals, Inc. Earnings Q2, 2015

    Ampio Pharmaceuticals, Inc. reports preliminary financial results for the quarter ended June 30, 2015.Ampio Pharmaceuticals, Inc. (AMPE-US) is one of the first companies amongst its peer group to announce earnings for this period.HighlightsSummary numbers: Revenues of USD 0.18 million, Net Earnings of USD -7.36 million, and Earnings per Share (EPS) of USD -0.14.Change in operating […] (Read more...) The post Ampio Pharmaceuticals, Inc. Earnings Q2, 2015 appeared first on CapitalCube.

  • Opening Bell, September 24, 2015
    CNBC Videos last year

    Opening Bell, September 24, 2015

    Ringing today's opening bell are Ampio Pharmaceuticals at the NYSE, and Nordnet AB at the Nasdaq, with CNBC's Jim Cramer.